Case report: A 51-year-old diabetic patient with primary bilateral macronodular adrenal hyperplasia and primary hyperparathyroidism

被引：0

作者：

Zhong, Yuan ^{[1
]}

Zhang, Tao ^{[2
]}

Li, Fan ^{[3
]}

Chen, Yong ^{[4
]}

Tong, Liwei ^{[5
]}

Xia, Chenxi ^{[1
]}

Wei, Dong ^{[1
]}

机构：

[1] Chengdu Second Peoples Hosp, Dept Endocrinol, Chengdu, Peoples R China

[2] Chengdu Second Peoples Hosp, Dept Med Imaging, Chengdu, Peoples R China

[3] Chengdu Second Peoples Hosp, Dept Pathol, Chengdu, Peoples R China

[4] Chengdu Second Peoples Hosp, Dept Urol, Chengdu, Peoples R China

[5] Zigong Fourth Peoples Hosp, Dept Endocrinol, Zigong, Peoples R China

来源：

FRONTIERS IN ENDOCRINOLOGY | 2024年 / 15卷

关键词：

primary bilateral macronodular adrenal hyperplasia; primary hyperparathyroidism; type 2 diabetes mellitus; Cushing's syndrome; multiple endocrine neoplasia type 1 (MEN 1);

D O I：

10.3389/fendo.2024.1383987

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A 51-year-old female patient with diabetes mellitus and hypertension, exhibiting poor control of blood sugar and blood pressure, was unexpectedly found to have multiple large adrenal nodules, excessive cortisol secretion, and adrenocorticotropic hormone inhibition. Cortisol levels remained unresponsive to both low-dose and high-dose dexamethasone tests, leading to a diagnosis of primary bilateral macronodular adrenal hyperplasia. Concurrently, elevated blood calcium and parathyroid hormone levels, along with 99mTc-methoxyisobutyl isonitrile (99mTc-MIBI) imaging revealing increased 99mTc-MIBI uptake in the right inferior parathyroid gland, suggest the consideration of primary hyperparathyroidism. This case is presented in light of the uncommon clinical coexistence of primary bilateral macronodular adrenal hyperplasia and primary hyperparathyroidism.

引用

页数：6

共 8 条

[1] Bouys L., Chiodini I., Arlt W., Reincke M., Bertherat J., Update on primary bilateral macronodular adrenal hyperplasia (PBMAH), Endocrine, 71, pp. 595-603, (2021)
[2] Lacroix A., Ndiaye N., Tremblay J., Hamet P., Ectopic and abnormal hormone receptors in adrenal Cushing’s syndrome, Endocr Rev, 22, (2001)
[3] Lacroix A., Baldacchino V., Bourdeau I., Hamet P., Tremblay J., Cushing’s syndrome variant secondary to aberrant hormone receptors, Trends Endocrinol Metab, 15, (2004)
[4] Lacroix A., Heredity and cortisol regulation in bilateral macronodular adrenal hyperplasia, N Engl J Med, 369, (2013)
[5] Louiset E., Duparc C., Young J., Renouf S., Tetsi Nomigni M., Boutelet I., Et al., Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia, N Engl J Med, 369, (2013)
[6] Ohashi A., Yamada Y., Sakaguchi K., Inoue T., Kubo M., Fushimi H., A natural history of adrenocorticotropin-independent bilateral adrenal macronodular hyperplasia (AIMAH) from preclinical to clinically overt Cushing’s syndrome, Endocr J, 48, (2001)
[7] Bertherat J., Bourdeau I., Bouys L., Chasseloup F., Kamenicky P., Lacroix A., Clinical, pathophysiologic, genetic, and therapeutic progress in primary bilateral macronodular adrenal hyperplasia, Endocr Rev, 44, pp. 567-628, (2023)
[8] Liu Q.-H., Nie X., He Y., Yin M.T., Li G.X., Value of baseline calcitonin for differential diagnosis of medullary thyroid cancer, Sichuan Da Xue Xue Bao Yi Xue Ban, 54, (2023)

← 1 →